EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Impact of IGFBP-3 A-202C genetic variant on breast cancer susceptibility and serum biomarkers (IGFBP-3 and IGF-1) in Palestinian women

Heba Mohammed Arafat iD, Tengku Ahmad Damitri Al-Astani iD, Noorazliyana Shafii iD, Rosediani Muhamad iD, Ohood Mohammed Shamallakh, Ihab Naser, Nahed Al Laham, Alaa Siddig

PLOS One · 2025

DOI: 10.1371/journal.pone.0325289 ↗

Kurz gefasst

Fachartikel in der Zeitschrift PLOS One, 2025. Verfasst von Heba Mohammed Arafat und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Chemical Pathology, School of Medical Sciences, Health Campus, Universiti Sains Malaysia, Kubang Kerian, Kelantan, Malaysia. Hauptthemen laut MEDLINE: Insulin-Like Growth Factor Binding Protein 3, Insulin-Like Growth Factor I, Breast Neoplasms, Genetic Predisposition to Disease. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 30 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Breast cancer is the most common diagnosed cancer and the leading cause of cancer-related deaths among women globally. This study examined the impact of insulin-like growth factor binding protein-3 (IGFBP-3) A-202C polymorphism (rs2854744) on breast cancer risk and its association with insulin-like growth factor-1 (IGF-1) and IGFBP-3 serum levels among Palestinian women in the Gaza Strip. Understanding these genetic variants could guide the development of early detection strategies and personalized interventions for breast cancer in underrepresented populations. A case-control study involved 112 women with newly diagnosed breast cancer and 222 healthy controls. Genotyping of the IGFBP-3 A-202C polymorphism was performed using polymerase chain reaction and restriction fragment length polymorphism (PCR-RFLP), and serum IGFBP-3 and IGF-1 levels were measured. The CC genotype of IGFBP-3 A-202C was observed in 70.5% of cases and 20.7% of controls, conferring a 16-fold increased breast cancer risk (OR=16.237; 95%CI 7.904, 33.356, p ≤ 0.001). The AC genotype was found in 19.6% of cases and 32.4% of controls, also associated with ~ 3-fold increased risk (OR=2.889; 95%CI 1.319, 6.325, p = 0.008). The CC genotype conferred a 28-fold increased risk in premenopausal women (OR=28.050; 95%CI 10.281, 76.527, p ≤ 0.001) and 5-fold in postmenopausal women (OR=5.333; 95%CI 1.711, 16.620, p = 0.004). Women with the CC genotype had the highest mean serum IGF-1 levels (116.49 ng/mL, p ≤ 0.001) and IGFBP-3 levels (3.76 µg/mL, p = 0.006) compared to those with the AA genotype. Positive correlations were observed between IGFBP-3 polymorphism and serum IGF-1 ( r s = 0.175, p ≤ 0.001) and IGFBP-3 levels ( r s = 0.164, p = 0.003). The IGFBP-3 A-202C polymorphism, especially the CC genotype, is strongly associated with elevated serum IGFBP-3 and IGF-1 levels and increased breast cancer risk, highlighting its potential as a biomarker for breast cancer screening and risk stratification. Further studies are needed to validate these findings in diverse populations.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Insulin-Like Growth Factor Binding Protein 3Insulin-Like Growth Factor IBreast NeoplasmsGenetic Predisposition to DiseaseBiomarkers, TumorPolymorphism, Single NucleotideHumansFemaleMiddle AgedCase-Control StudiesArabsAdultGenotypeAgedMiddle East

Substanzen

Insulin-Like Growth Factor Binding Protein 3Insulin-Like Growth Factor IIGFBP3 protein, humanBiomarkers, TumorIGF1 protein, human

Autor:innen und Institutionen

  • Department of Chemical Pathology, School of Medical Sciences, Health Campus, Universiti Sains Malaysia, Kubang Kerian, Kelantan, Malaysia.
  • Department of Family Medicine, School of Medical Sciences, Health Campus, Universiti Sains Malaysia, Kubang Kerian, Kelantan, Malaysia.
  • Department of Medical Laboratory Sciences, Faculty of Health Sciences, Islamic University of Gaza, Gaza City, Palestine.
  • Department of Clinical Nutrition, Faculty of Applied Medical Sciences, Al-Azhar University- Gaza, Gaza City, Palestine.
  • Department of Laboratory Medicine, Al Azhar University-Gaza, Gaza City, Palestine.
  • Department of Pathology, School of Medical Sciences, Universiti Sains Malaysia, Kelantan, Malaysia.

ORCID-Profile: Heba Mohammed Arafat, Tengku Ahmad Damitri Al-Astani, Noorazliyana Shafii, Rosediani Muhamad

Zitieren

APA

Arafat, H. M., Al-Astani, T. A. D., Shafii, N., Muhamad, R., Shamallakh, O. M., Naser, I., Al Laham, N., & Siddig, A. (2025). Impact of IGFBP-3 A-202C genetic variant on breast cancer susceptibility and serum biomarkers (IGFBP-3 and IGF-1) in Palestinian women. PLOS One. https://doi.org/10.1371/journal.pone.0325289

Vancouver

Arafat HM, Al-Astani TAD, Shafii N, Muhamad R, Shamallakh OM, Naser I, et al. Impact of IGFBP-3 A-202C genetic variant on breast cancer susceptibility and serum biomarkers (IGFBP-3 and IGF-1) in Palestinian women. PLOS One. 2025. doi:10.1371/journal.pone.0325289

BibTeX
@article{Arafat2025,
  author = {Arafat, Heba Mohammed and Al-Astani, Tengku Ahmad Damitri and Shafii, Noorazliyana and Muhamad, Rosediani and Shamallakh, Ohood Mohammed and Naser, Ihab and Al Laham, Nahed and Siddig, Alaa},
  title = {Impact of IGFBP-3 A-202C genetic variant on breast cancer susceptibility and serum biomarkers (IGFBP-3 and IGF-1) in Palestinian women},
  journal = {PLOS One},
  year = {2025},
  doi = {10.1371/journal.pone.0325289}
}
Kostenlos starten →